Tekmira Pharmaceuticals Corporation
logo BDC

Tekmira Pharmaceuticals Corporation

Tekmira is a leader in the development of the therapeutic agents based upon Nobel prize-winning breakthroughs in the field of gene silencing, known as RNA interference (RNAi). Tekmira’s three lead RNAi product candidates target cholesterol management, cancer and Ebola infection.

Investment year:  2002
Industry sector:  Biotechnology
Region:  Prairies and West
Website
Follow Tekmira Pharmaceuticals Corporation
v17.9.0.10395